Newsroom
Hier finden Sie unsere Neuigkeiten

News

  • Mobility-Shift-Assay-Detektionssystem der nächsten Generation! General

    Mobility-Shift-Assay-Detektionssystem der nächsten Generation!

    Wir haben tolle Neuigkeiten für Sie: MSA ist für Ihre Inhibitorforschung weiterhin zugänglich!

    Read more
  • Biotinylierte Kinasen General

    Biotinylierte Kinasen

    Wir haben neue Produkte: biologisch biotinylierte humane Kinasen von Carna Biosciences.

    Read more
  • New Cellular CDK Assay Panel Launched and Special Offers from Carna Offers

    New Cellular CDK Assay Panel Launched and Special Offers from Carna

    We are pleased to launch a new CDK (cyclin-dependent kinases) Cell-based Assay Panel for kinase researchers who are focusing on the CDK family.

    Read more
  • Neue Website online! General

    Neue Website online!

    Wir freuen uns sehr, den Start unserer neuen Website bekannt geben zu können!

    Wir haben beschlossen, dass es an der Zeit für einen neuen Look ist,…

    Read more
  • First
  • «
  • 1
  • »
  • Last

Carna Biosciences Newsletter

  • Newsletter

    Cancer treatments using inhibitors of CDK, a cell cycle regulator

    Carna Newsletter Vol.16

    Read more
  • Newsletter

    ALK drug resistant mutations: Challenges for the treatment of lung cancer

    Carna Newsletter Vol.15 

     

    Read more
  • Technical Note

    DGKα and DGKζ are key targets for cancer immunotherapy

    Carna Newsletter Vol.14

    Read more
  • Newsletter

    The potential of PIKfyve inhibitor as a treatment of amyotrophic lateral sclerosis (ALS)

    Carna Newsletter Vol.13

    Read more
  • Newsletter

    The importance of understanding the activity of compounds on RAF dimerization in BRAF inhibitor drug discovery

    Carna Biosciences Newsletter Vol. 12

    Read more
  • Newsletter

    Kinase Inhibitors as Potential Therapeutic Agents for COVID-19

    Carna Biosciences Newsletter Vol. 11

    Read more
  • Technical Note

    Evaluating Kinase Inhibitors in Binding Assays using Activated and Non-Activated Biotinylated Kinases

    Carna Biosciences Technical Note No. 1

    Read more
  • Newsletter

    Targeted Degradation of Non-catalytic Kinases New Drug Discovery Options

    Carna Biosciences Newsletter Vol. 10

    Read more
  • Newsletter

    Drug-resistant EGFR mutations in lung cancer

    Carna Biosciences Newsletter Vol. 9

    Read more
  • Newsletter

    Kinetic analysis of covalent and irreversible inhibitors

    Carna Biosciences Newsletter Vol. 8

    Read more
  • Technical Note

    The importance of assessing intrinsic target kinase activity

    Carna Biosciences Technical Note No. 2

    Read more
  • Technical Note

    Production of Highly Active Protein Kinases for Drug Discovery Applications

    Carna Biosciences Technical Note No. 1

    Read more
  • Newsletter

    Kinase Inhibitors in the Fight against COVID-19

    Carna Biosciences Newsletter Vol. 7

    Read more
  • Newsletter

    Recommendations for off-target profiling

    Carna Biosciences Newsletter Vol. 6

    Read more
  • Newsletter

    The significance of ATP concentration in cell-free and cell-based assays

    Carna Biosciences Newsletter Vol. 4

    Read more
  • Newsletter

    Targeted Protein Degraders

    Carna Biosciences Newsletter Vol. 3

    Read more
  • Newsletter

    Residence time and compound selectivity

    Carna Biosciences Newsletter Vol. 2

    Read more
  • Newsletter

    A story about biotin-avidin affinity and how it accelerates small molecule drug discovery

    Carna Biosciences Newsletter Vol. 1

    Read more
  • First
  • «
  • 1
  • 2
  • 3
  • »
  • Last
Scientist typing on Laptop

Newsletter

Newsletter abonnieren Icon
Kontakt